Position in COLL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$517,479
+$171,005 QoQ
Shares Held
14,295
+36.4% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#139
of 277 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BOKF, NA holds $12,347,827 across 8 Drug Manufacturers - Specialty & Generic names. COLL ranks #4 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
6,977 | $3,780,347 | |
| 2 | VTRS |
Viatris Inc
|
222,511 | $3,533,474 | |
| 3 | ZTS |
Zoetis Inc.
|
37,061 | $2,663,202 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
This page
|
14,295 | $517,479 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
4,610 | $511,433 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
6,015 | $497,921 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
10,324 | $488,015 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
2,112 | $355,956 |
All Filings in COLL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $517,479 | 14,295 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $346,474 | 10,477 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $728,390 | 15,732 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $553,401 | 15,816 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $465,549 | 15,744 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $466,644 | 15,633 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $484,843 | 16,923 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $522,411 | 13,520 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $489,697 | 15,208 | Shares | Defined | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||